Intuitive Surgical, Inc. (ISRG) Return on Equity (ROE): 17.05%
Is Intuitive Surgical, Inc.’s return on equity (ROE) high or low?
Intuitive Surgical, Inc.'s return on equity (ROE) of 17.05% is 27% above its 5-year average of 13.46%, near the high end of its 5-year range (10.87%–16.02%).
The return on equity (ROE) for Intuitive Surgical, Inc. (ISRG) is 17.05% as of Wednesday, June 10, 2026. It is above its 12-month average by 13.10% (15.07%).
ISRG Return on Equity (ROE) Chart
ISRG Average Return on Equity (ROE) Chart
ISRG Current vs Average Return on Equity (ROE) Chart
ISRG Return on Equity (ROE) Metrics
RETURN ON EQUITY (ROE)
17.05%
RETURN ON EQUITY (ROE) AVG TTM
15.07%
RETURN ON EQUITY (ROE) AVG 3Y
13.91%
RETURN ON EQUITY (ROE) AVG 5Y
13.46%
RETURN ON EQUITY (ROE) AVG 10Y
14.06%
RETURN ON EQUITY (ROE) AVG 15Y
15.12%
RETURN ON EQUITY (ROE) AVG 20Y
15.38%
CURRENT VS TTM AVG
+13.10%
CURRENT VS 3Y AVG
+22.57%
CURRENT VS 5Y AVG
+26.66%
CURRENT VS 10Y AVG
+21.28%
CURRENT VS 15Y AVG
+12.74%
CURRENT VS 20Y AVG
+10.85%
ISRG Competitors' Return on Equity (ROE)
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intuitive Surgical, Inc. (ISRG) | $146.44B | 17.05% | 15.07% | 13.91% | 13.46% |
| Pfizer Inc. (PFE) | $146.36B | 8.31% | 9.04% | 13.32% | 16.07% |
| Gilead Sciences, Inc. (GILD) | $151.21B | 39.19% | 20.05% | 21.63% | 19.46% |
| Abbott Laboratories (ABT) | $154.66B | 12.06% | 20.32% | 18.59% | 17.97% |
| Danaher Corporation (DHR) | $130.25B | 6.97% | 7.38% | 9.51% | 10.24% |
| CVS Health Corporation (CVS) | $125.16B | 3.79% | 4.23% | 6.35% | 7.74% |
| Bristol-Myers Squibb Company (BMY) | $114.14B | 36.25% | -8.30% | 7.76% | 4.45% |
| Thermo Fisher Scientific Inc. (TMO) | $179.45B | 13.21% | 12.70% | 13.51% | 15.24% |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.77B | 22.41% | 8.96% | 15.60% | 19.47% |
| Amgen Inc. (AMGN) | $183.75B | 84.87% | 79.33% | 111.35% | 101.76% |
Return Analysis
ROE
17.1%
ROA
14.8%
Intuitive Surgical, Inc. Return on Equity (ROE) Formula & Definition
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Intuitive Surgical, Inc. Return on Equity (ROE) FAQ
- What is the return on equity (ROE) for Intuitive Surgical, Inc. (ISRG)?
- The return on equity (ROE) for ISRG stock is 17.05%.
- Is Intuitive Surgical, Inc.'s return on equity (ROE) high or low?
- Intuitive Surgical, Inc.'s return on equity (ROE) of 17.05% is 27% above its 5-year average of 13.46%, near the high end of its 5-year range (10.87%–16.02%).
- What is the TTM average return on equity (ROE) for Intuitive Surgical, Inc. (ISRG)?
- The TTM average return on equity (ROE) for ISRG stock is 15.07%.
- What is the 3Y average return on equity (ROE) for Intuitive Surgical, Inc. (ISRG)?
- The 3Y average return on equity (ROE) for ISRG stock is 13.91%.
- What is the 5Y average return on equity (ROE) for Intuitive Surgical, Inc. (ISRG)?
- The 5Y average return on equity (ROE) for ISRG stock is 13.46%.
- What is the 10Y average return on equity (ROE) for Intuitive Surgical, Inc. (ISRG)?
- The 10Y average return on equity (ROE) for ISRG stock is 14.06%.
- What is the 15Y average return on equity (ROE) for Intuitive Surgical, Inc. (ISRG)?
- The 15Y average return on equity (ROE) for ISRG stock is 15.12%.
- What is the 20Y average return on equity (ROE) for Intuitive Surgical, Inc. (ISRG)?
- The 20Y average return on equity (ROE) for ISRG stock is 15.38%.
Intuitive Surgical, Inc. Return on Equity (ROE) History
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | 16.02% |
| 2024-12-31 | 14.13% |
| 2023-12-31 | 13.51% |
| 2022-12-31 | 11.98% |
| 2021-12-31 | 14.26% |
| 2020-12-31 | 10.87% |
| 2019-12-31 | 16.65% |
| 2018-12-31 | 16.89% |
| 2017-12-31 | 13.96% |
| 2016-12-31 | 12.74% |
| 2015-12-31 | 13.63% |
| 2014-12-31 | 12.39% |
| 2013-12-31 | 19.16% |
| 2012-12-31 | 18.34% |
| 2011-12-31 | 18.71% |
| 2010-12-31 | 18.74% |
| 2009-12-31 | 15.13% |
| 2008-12-31 | 16.13% |
| 2007-12-31 | 16.26% |
| 2006-12-31 | 12.22% |
| 2005-12-31 | 21.27% |
| 2004-12-31 | 7.45% |
| 2003-12-31 | -3.45% |
| 2002-12-31 | -28.93% |
| 2001-12-31 | -21.33% |
| 2000-12-31 | -20.42% |
| 1999-12-31 | -82.91% |
| 1998-12-31 | -142.95% |
Related Metrics
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- David J. Rosa